Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Male

Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.

5,032 public trials 1,031 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Male trial results

Completed

Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

NCT03834519

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • St. Joseph Heritage Healthcare ( Site 0069) Fullerton, California, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 0081) Los Angeles, California, United States
  • Sibley Memorial Hospital ( Site 0096) Washington D.C., District of Columbia, United States
  • Georgia Cancer Center at Augusta University ( Site 0026) Augusta, Georgia, United States
View all 193 locations
View Trial Details
Completed

Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer

NCT02788773

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
View Trial Details

Related conditions